by Greg Brown and Arzu Ozoguz — January 22, 2021 .
Editor’s note: Greg Brown is Executive Director, Kenan Institute of Private Enterprise; Sarah Graham Kenan Distinguished Professor of Finance, UNC Kenan-Flagler Business School; Arzu Ozoguz is Clinical Associate Professor of Finance, UNC Kenan-Flagler Business School.
CHAPEL HILL – Despite the current political drama playing out in Washington, hope remains for a better 2021. The approvals of the Pfizer-BioNTech and Moderna vaccines provide a clear path for an end to the coronavirus pandemic that challenged almost every aspect of our lives in 2020. But a recent resurgence of the virus and increasing rates of infection indicate that a full return to normalcy—including when and how we go back to the office—is still months in the future.